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ABSTRACT: The Siddha Drugs sivannar Amirthan (SA), Ayakkantha chendooram (AC) and 
their combinations were screened for their antiinflammatory effect against carrageenin induced 
paw edema and for its protective effect on mast cellos against degranulation, A significant 
antiinflammatory and mast cell protective effects were observed. 
 
INTRODUCTION 
 
The siddha drugs Sivannar amirtham (S.A), 
Ayakkantha chendooram (AC were sued for 
various ailments, the constituents of the SA 
and AC were given in the table 1.  The 
combination of these drugs were used in a 
variety of inflammatory conditions. SA is 
used in rheumatic diseases, respiratory 
diseases, bronchial asthma, piles and also in 
tuberculosis. AC is used in ascites and in all 
types of enaemia
1
. 
 
Table 1 
Constituents of the Drugs 
 
Sivannaar Amirtham  Ayakkantha chendooram 
Male fern rhizome 
Mercury  
Aconite 
Sulphur 
Three pungents 
Red Orpiment 
Borax 
Black pepper 
Iron filings  
Lode stone 
Cinnabar 
Borax 
Common alum 
Alkaline earth salt  
common salt 
rock salt 
Salammoniac 
Camphor 
Lime juice 
 
MATERIALS AND METHODS 
 
Sivanaar amirtham (SA) and Ayakkantha 
chendooram (AC) were procured form 
IMPCOPS, Chennai. 
 
Carrageenin induced paw edema
2 
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Paw edema was in albino rats weighing 
(150-200 gms) by injecting 0.1 ml of 1% 
carrageenin.  The rats were divided into five 
groups of six each.  The dosage of the drugs 
administered to the different groups was as 
follows. Group I SA (125 mg/kg), Group II-
AC (125 mg/kg) Group III – AC (125 
mg/kg) Group III SA+AC (65mg/kg +65 
mg/kg), Group IV – Indomethacin (10 mg/ 
kg), all the above druge were prepared in a 
five suspension with honey and water as 
indicated in the siddha literature1 group V-
serves as solvent control and received 0.5ml 
of the mixture of honey and water.  All the 
drug ewer administered.  The increase in 
paw volume was measured 
plethysmographically every hour upto 8 hrs . 
 
Mast Cell degranulation 
 
In vitro test for mast cell degranulation was 
carried out by the modified method of kaley 
and Weiner (1971)3 Male albino rats were 
sacrificed, the mesentry was carefully 
removed and cut into small bits of about one 
cm.  these bits were incubated for 5 min in 
tyrode solution containing SA (100 mcg/ml) 
were added to the incubates and the bits 
were removed after 10 min. they were 
carefully spread over glass slides and stained 
with 1% toluidine blue. Mast cells were 
counted in5 different fields at random under 
high power objective field, the percentage of 
degranulated cells were calculated in each 
treatment group.  Disodium cromoglycate 
(DSCG), a known mast cell stabilizer was 
included in the study for comparison.  All 
results were analyzed using students‘t’ test. 
 
Table No 2 
Effect of SA and AC on carrageenin induced paw edema in albino rats 
 
% increase in paw volume (mean ±SE n=6) 
Post insult time of assay in minute 
Drug 
And 
Dose 
  0 60  120  180  240  360  480 
Vehicle  52.4 ±4.7  57.3± 4.9  82.6 ±5.7  101.6 
±8.4 
109.6 ± 
8.7 
109.6 
±8.7 
108.3 
±8.2 
Indo 
(10mg/kg) 
35.3 ±3.0  52.3 ±4.4  72.0 ±6.5  74.3 ±6.7  74.3 
±6.7 
72.0± 
6.5 
72.0 
±6.5 
SA 
(125mg/kg) 
50.3 v4.2  57.0 ±6.6  82.0 ±7.6  91.6 ±6.7  94.3± 
6.7 
86.3± 
8.1 
85.3± 
7.8 
AC 
(125mg/kg) 
29.3 ±4.0  38.0 ±3.8  44.3 ±5.6  47.6 ±5.8  47.6 
±5.7 
55.6 
±5.7 
55.0± 
5.6 
SA+AC 
(65mg/kg) 
42.3 ±4.1  48.6 ±4.4  69.3 ±6.2  69.3± 6.2  76.3 
±4.5 
69.3± 
4.4 
67.3 
±4.2 
 
RESULTS AND DISCUSSION  
Carrageenin Paw edema 
 
Treatment with SA and AC produced 
significant reduction in the volume of paw 
edema (Table -2) It as been reported that the 
second phase of carrageenin induced 
inflammation is said to be promoted by 
prostaglandin, and this phase is sensitive to 
drugs like indomethacin, phenlybutazone, 
and hydrocortisone. 4,5 It was noticed that 
the siddha drugs SA and AC exert maximum 
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anti-inflammatory activity at the second 
phase of carrageenin inflammation. 
 
Mast cell degranulation 
 
Propranolol (50mcg/ml) produced 6.3 = 4.1 
% degranulation of rat mesenteric mast 
cells. Pretreatment with SA and AC 
significantly reduced percentage of 
degranulation (table-3). The rupture of mast 
cell membrane and degranulation are 
important stages in the allergic reaction.   
The present study revealed tem as cell 
stabilizing effect of SA and AC. 
 
Table – 3 
Effect of SA and AC on mast cell degranulation 
 
Treatment MCG/ml  Saline  Propranolol 50 mcg/ml % degranulation  
Control 
SA 
100 
AC 
100 
DSCG 
10 
30.4 ± 3.0  66.3 ± 4.1 
 
19.6 ± 1.1* 
 
13.2 ± 0.8* 
 
22.3 ± 1.4 * 
   
Each value represents the mean ± SEM of six expertiments. *P< 0.001 compared to control 
value. 
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